Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis
Guillermo Antonio De Paz Linares, R. Opperman, Mousumi Majumder, P. Lala
Cancers